Introduction
Heterocycles are important molecular building blocks that are involved in the structural composition of crucial chemicals for humans, including pharmaceuticals, natural resources, veterinary and agricultural products, analytical reagents, and dyes. Imidazo [1,2-a] pyridine, a fused bicyclic 5-6-heterocycle with 1 ring junction nitrogen atom and 1 extra nitrogen atom in the 5-membered ring, is of interest because of the occurrence of its derivatives in biologically active compounds and the pharmacology of the system has also been extensively investigated.
1
Human fungal infections have increased in the last 2 decades due to the increasing number of immunocompromised patients or those undergoing anticancer chemotherapy or transplantation. 2 On the other hand, the current antifungal therapy suffers from toxicity, nonoptimal pharmacokinetics, and some serious adverse drug interactions. New chemotherapeutic agents with higher efficiency, a broader spectrum, and lower toxicity are urgently needed for the treatment of fungal infections.
3
In previous papers, we reported the synthesis and biological activity of a series of imidazo[1,2-a]pyridines as antibacterials and antifungals. 4−6 The present work is an extension of our ongoing efforts toward the development and identification of new antifungal imidazo[1,2-a]pyridine derivatives bearing hydrazinecarbothioamide (4a-j), 1,3-thiazolidine (5a-f ), or 1,3,4-oxadiazole (6a-d) moieties. * Correspondence: fusung@istanbul.edu.tr
Results and discussion

Chemistry
Ethyl imidazo [1,2-a] pyridine-2-carboxylate hydrobromide (2) was obtained from 2-aminopyridine and ethyl bromopyruvate by a 2-step procedure. 7 Heating 2 with hydrazine in ethanol gave imidazo[1,2-a ]pyridine-2-carbohydrazide (3), 8 and 3 was reacted with alkyl or aryl isothiocyanates to achieve 2-(imidazo [ R= CH 3 (5a), C 2 H 5 (5b), C 3 H 7 (5c), CH 2 C 6 H 5 (5d), CH 2 CH 2 C 6 H 5 (5e), 4-CH 3 C 6 H 4 (5f) Scheme 1. Synthesis of compounds 4-6.
The structures of compounds 4a-j were assigned by elemental analyses and spectral data; 4a-j were confirmed by their IR spectra, which displayed absorption peaks at 3395-3106 cm The purity of the synthesized compounds was established by elemental analysis.
Antifungal activity
The antifungal activities of compounds 4a-c, f -j, 5a, b, f, and 6a-d were investigated against Microsporum gypseum NCPF 580, M. canis, Trichophyton tonsurans NCPF 245, T. rubrum, Candida albicans ATCC 10231, and C. parapsilosis ATCC 22019 by microdilution method. Antifungal activity data are given in the Table. All tested compounds exhibited varying degrees of antifungal activity; the highest activities were demonstrated by compounds 4h and 4f against M. canis at 2 µ g mL −1 and 4 µ g mL −1 , respectively. spectrophotometers using TMS as the internal standard. 13 C NMR spectra were recorded at 150 and 75 MHz using the instruments mentioned above. EI and APCI mass spectra were determined with a Finnigan LCQ mass spectrometer. Elemental analyses were performed on a Thermo Finnigan Flash EA1112. Chemicals were purchased from Merck (Darmstadt, Germany), Fluka, and Sigma-Aldrich Chemical Co.
2-Amino-1-(3-ethoxy-2,3-dioxopropyl)pyridinium bromide (1)
7
To a suspension of 2-aminopyridine (0.09 mol) in dimetoxyethane (50 mL) was added ethylbromopyruvate (0.1 mol) and the reaction mixture was stirred for 2 h at room temperature. The precipitate was filtered, washed with H 2 O, and used without further purification.
Ethyl imidazo[1,2-a]pyridine-2-carboxylate hydrobromide (2)
Compound 1 (0.04 mol) in ethanol 96% (100 mL) was refluxed for 2 h. Ethanol was evaporated to 1/5 volume under reduced pressure, and then ether was added to give a solid residue. The crude product was filtered and used without further purification. 
Imidazo[1,2-a]pyridine-2-carbohydrazide (3)
General procedure for the synthesis of 2-(imidazo[1,2-a]pyridin-2-ylcarbonyl)-N -substituted hydrazinecarbothioamide (4a-j)
First 0.075 mol of 3, 0.075 mol of appropriate alkyl/aryl isothiocyanate, and 40 mL of absolute ethanol were refluxed 30 min. The solid formed was filtered and recrystallized from ethanol (96%). 
2-(Imidazo[1,2-a]pyridin-2-ylcarbonyl)-N -methylhydrazinecarbothioamide (4a
N -(4-Bromophenyl)-2-(imidazo[1,2-a]pyridin-2-ylcarbonyl)hydrazinecarbothioamide (4i).
Yield 
N -(4-Fluorophenyl)-2-(imidazo[1,2-a]pyridin-2-ylcarbonyl)hydrazinecarbothioamide (4j).
Yield The appropriate hydrazinecarbothioamides (4f -j) (0.0035 mol) were suspended in ethanol 96% (30 mL), and aqueous sodium hydroxide (5 mL, 4 N) and iodine in potassium iodide solution (aqueous 5%) were added with shaking at room temperature until the color of iodine persisted. The solid separated was filtered, and purified by crystallization from ethanol 96%. 
5-(Imidazo[1,2-a]pyridin-2-yl)-N -phenyl-1,3,4-oxadiazol-2-amine (6a
Antifungal activity
Microdilution was conducted according to a standard protocol by the National Committee for Clinical Laboratory Standards (NCCLS). 18, 19 RPMI 1640 broth with L-glutamine without sodium bicarbonate was used and buffered with 3-(N-morfolino) propanesulfonic acid (MOPS). The medium was adjusted to pH 7.0 at 25 • C. Amphotericin B was provided by Sigma as the standard. All compounds were dissolved in 100% dimethylsulfoxide according to NCCLS methods. 18, 19 The final concentrations were 64 to 0.03 µ g/mL for all compounds.
Preparation of inoculum suspensions was based mainly on the NCCLS guidelines and described previously. 19, 20 The isolates were subcultured onto potato dextrose agar (PDA) plates at 28
• C, over 7-14 days.
The fungal colonies were covered with 1 mL of sterile 0.85% saline, and suspensions were made by gently probing the surface with the tip of a Pasteur pipette. The resulting mixture of conidia and hyphal fragments was withdrawn and transferred to a sterile tube. Heavy particles were allowed to settle for 15-20 min at room temperature; the upper suspension was mixed with a vortex for 15 s. The turbidity of supernatants was measured spectrophotometrically at 530 nm, and transmission was adjusted to 65% to 75%. These stock suspensions were diluted 1:50 in RPMI medium to obtain the final inoculum sizes, which ranged from 0.4 × 10 4 to 5 × 10 4 CFU/mL.
Preparation of inoculum suspensions of C. albicans and C. parapsilosis was based mainly on the NCCLS guidelines 18 and described previously. 21 Yeasts were grown on Sabouraud dextrose agar for 24 h at 35 • C and from the 24-to 48-h-old culture was suspended in 5 mL of sterile 0.85% saline.
The turbidity of mixed suspension was measured at 530 nm to obtain 75% to 77% transmission and adjusted to 1 × 10 6 to 5 × 10 6 CFU/mL by spectrophotometric method. These stock suspensions were diluted 1:50 in RPMI medium, and further diluted 1:20 with medium to obtain the 2-fold test inoculum (1 × 10 3 to 5 × 10 3 CFU/mL). The (2-fold) inoculum was diluted 1:1 when wells were inoculated and the desired final inoculum size was achieved (0.5 × 10 3 to 2.5 × 10 3 CFU/mL).
Microdilution plates (96 U-shaped) were prepared and frozen at -70 • C until needed. Rows 2 to 12 contained the series of compound dilutions in 100-µ L volumes and the first row contained 100 µ L of compoundfree medium, which served as the growth control. Each well was inoculated on the day of the test with 100 µ L of the corresponding inoculum. This step brought the compound dilutions and inoculum size to the final test concentrations given above. The microplates of dermatophytes were incubated at 28
• C for 7 days and the microplates of yeasts were incubated at 35
• C for 24 and 48 h. The microplates were read visually with the aid of an inverted reading mirror after 7 days for dermatophytes and after 24 and 48 h for yeasts. For all compounds, the MIC was defined as the lowest concentration showing 100% inhibition of growth.
